Azathioprine + Ustekinumab Interaction
Moderateinteraction on record
Description
Immunomodulator used concomitantly in approximately 30% of subjects with Crohn's disease and ulcerative colitis; did not appear to influence overall safety or efficacy.
Source: NLP:ustekinumab